Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6015980
Reference Type
Journal Article
Title
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Author(s)
Callanan, JJ; Shokry, IM; Sousa, J; Tao, R
Year
2015
Is Peer Reviewed?
1
Journal
Journal of Visualized Experiments
EISSN:
1940-087X
Book Title
J Vis Exp. 2015, Sep 23. [Journal of visualized experiments : JoVE]
Language
English
Abstract
3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) toxicity may cause region-specific changes in serotonergic mRNA expression due to acute serotonin (5-hydroxytryptamine; 5-HT) syndrome. This hypothesis can be tested using in situ hybridization to detect the serotonin 5-HT2A receptor gene htr2a. In the past, such procedures, utilizing radioactive riboprobe, were difficult because of the complicated workflow that needs several days to perform and the added difficulty that the technique required the use of fresh frozen tissues maintained in an RNase-free environment. Recently, the development of short oligonucleotide probes has simplified in situ hybridization procedures and allowed the use of paraformaldehyde-prefixed brain sections, which are more widely available in laboratories. Here, we describe a detailed protocol using non-radioactive oligonucleotide probes on the prefixed brain tissues. Hybridization probes used for this study include dapB (a bacterial gene coding for dihydrodipicolinate reductase), ppiB (a housekeeping gene coding for peptidylprolyl isomerase B), and htr2a (a serotonin gene coding for 5-HT2A receptors). This method is relatively simply, cheap, reproducible and requires less than two days to complete.
Keywords
Animals; Brain Chemistry; Cyclophilins/genetics; Dihydrodipicolinate Reductase/genetics; Fixatives/chemistry; Formaldehyde/chemistry; In Situ Hybridization/methods; N-Methyl-3,4-methylenedioxyamphetamine/toxicity; Oligonucleotide Probes; Paraffin Embedding/methods; Polymers/chemistry; RNA, Messenger/metabolism; Random Allocation; Receptor, Serotonin, 5-HT2A/genetics; Serotonin Syndrome/genetics/metabolism; Tissue Fixation/methods; 137497-17-7; 1HG84L3525
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity